Around 40–70% of HCCs show elevated Wnt/β‐catenin signaling activity, and CTNNB1 (encoding for β‐catenin) mutation frequencies increase significantly with HCC progression [35]. Here, CTNNB1 is linked to hepatocellular carcinoma.